National Comprehensive Cancer Network

Acute Myeloid Leukemia (AML)

• Arsenic Trioxide (Trisenox®) --- Teva Oncology: CORE (Comprehensive Oncology Reimbursement Expertise)

Basal Cell Carcinoma

• Vismodegib (Erivedge) --- Genentech Access Solutions

Bone Cancer

• Patient Access Network (PAN) Foundation (866.316.7263)
• Zoledronic acid (Zometa®) --- Patient Assistance NOW Oncology (PANO) (Novartis Oncology)

Breast Cancer

• Ado-trastuzumab emtansine (Kadcyla) --- Genentech Access Solutions
• Capecitabine (Xeloda)
• Ixabepilone (Ixempra®) --- Bristol-Myers Squibb Oncology: Reimbursement Services
• Letrozole (Femara®) --- Patient Assistance NOW Oncology (PANO) (Novartis Oncology)
• Paclitaxel, albumin-bound (Abraxane®) --- Celgene Patient Support®
• Patient Access Network (PAN) Foundation (866.316.7263)
• Pertuzumab (Perjeta) --- Genentech Access Solutions
• Trastuzumab (Herceptin) --- Genentech Access Solutions

Chronic Lymphocytic Leukemia

• Rituximab (Rituxan) --- Genentech Access Solutions

Chronic Myelogenous Leukemia (CML)

• Dasatinib (Sprycel®) --- Bristol-Myers Squibb Oncology: Reimbursement Services
• Imatinib (Gleevec®) --- Patient Assistance NOW Oncology (PANO) (Novartis Oncology)
• Nilotinib (Tasigna®) --- Patient Assistance NOW Oncology (PANO) (Novartis Oncology)
• ponatinib (Iclusig®) --- ARIAD PASS™ (Patient Access & Support Services

Colon Cancer

• Bevacizumab (Avastin) --- Genentech Access Solutions
• Capecitabine (Xeloda) --- Genentech Access Solutions
• Cetuximab (Erbitux®) --- Bristol-Myers Squibb Oncology: Reimbursement Services
• Patient Access Network (PAN) Foundation (866.316.7263)

Glioblastoma

• Bevacizumab (Avastin) --- Genentech Access Solutions

Head and Neck Cancers

• Cetuximab (Erbitux®) --- Bristol-Myers Squibb Oncology: Reimbursement Services

Hepatobiliary Cancers

• Sorafenib tosylate (Nexavar®) --- REACH (Resource for Expert Assistance and Care Helpline) (Bayer HealthCare Pharmaceuticals)

Hodgkin Lymphoma

• ADCETRIS (brentuximab vedotin) --- Seattle Genetics - SeaGen Secure
• Patient Access Network (PAN) Foundation (866.316.7263)

Kidney Cancer

• Bevacizumab (Avastin) --- Genentech Access Solutions
• Everolimus (Afinitor®) --- Patient Assistance NOW Oncology (PANO) (Novartis Oncology)
• Sorafenib tosylate (Nexavar®) --- REACH (Resource for Expert Assistance and Care Helpline) (Bayer HealthCare Pharmaceuticals)
• Patient Access Network (PAN) Foundation (866.316.7263)

Melanoma

• Ipilimumab (YERVOY™) --- Bristol-Myers Squibb Oncology: Reimbursement Services
• Vemurafenib (Zelboraf) --- Genentech Access Solutions

Multiple Myeloma

• Bendamustine (Treanda®) --- Teva Oncology: CORE (Comprehensive Oncology Reimbursement Expertise)
• Carfilzomib (Kyprolis™) --- Onyx Pharmaceuticals
• Patient Access Network (PAN) Foundation (866.316.7263)
• Lenalidomide (Revlimid®) --- Celgene Patient Support®
• Thalidomide (Thalomid®) --- Celgene Patient Support®

Myelodysplastic Syndromes

• Azacitidine for injection (Vidaza®) --- Celgene Patient Support^®
• Lenalidomide (Revlimid®) --- Celgene Patient Support®
• Patient Access Network (PAN) Foundation (866.316.7263)

Myelofibrosis

• Ruxolitinib (tablets) (Jakafi®) --- IncyteCARES (Incyte Corporation)
• Chronic Disease Fund (CDF) --- (877) YOUR-CDF (968-7233) or www.cdfund.org
• Patient Access Network (PAN) Foundation --- (866) 316-7263

Neuroendocrine Tumors

• Everolimus (Afinitor®) --- Patient Assistance NOW Oncology (PANO) (Novartis Oncology)

Non-Hodgkin's Lymphomas

• ADCETRIS (brentuximab vedotin) --- SeaGen Secure (855-4-SEAGEN)
• Bendamustine (Treanda®) --- Teva Oncology: CORE (Comprehensive Oncology Reimbursement Expertise)
• Imatinib (Gleevec®) --- Patient Assistance NOW Oncology (PANO) (Novartis Oncology)
• Patient Access Network (PAN) Foundation (866.316.7263)
• Rituximab (Rituxan) --- Genentech Access Solutions
• Romidepsin for injection (Istodax^®) --- Celgene Patient Support^®

Non-Melanoma Cancers

• Imatinib (Gleevec®) --- Patient Assistance NOW Oncology (PANO) (Novartis Oncology)
• Patient Access Network (PAN) Foundation (866.316.7263)

Non-Small Cell Lung Cancer

• Cetuximab (Erbitux®) --- Bristol-Myers Squibb Oncology: Reimbursement Services
• Erlotinib (Tarceva) --- Genentech Access Solutions
• Bevacizumab (Avastin) --- Genentech Access Solutions
• Patient Access Network (PAN) Foundation (866.316.7263)

Pancreatic Adenocarcinoma

• Erlotinib (Tarceva) --- Genentech Access Solutions
• Patient Access Network (PAN) Foundation (866.316.7263)

Prevention and Treatment of Cancer-Related Infections

• Patient Access Network (PAN) Foundation (866.316.7263)

Prostate Cancer

• Enzalutamide capsules (XTANDI) – XTANDI Access Services^SM
• Patient Access Network (PAN) Foundation (866.316.7263)

Rectal Cancer

• Cetuximab (Erbitux®) --- Bristol-Myers Squibb Oncology: Reimbursement Services
• Avastin --- Genentech Access Solutions
• Patient Access Network (PAN) Foundation (866.316.7263)

Soft Tissue Sarcoma

• Cetuximab (Erbitux®) --- Bristol-Myers Squibb Oncology: Reimbursement Services
• Dasatinib (Sprycel®) --- Bristol-Myers Squibb Oncology: Reimbursement Services
• Imatinib (Gleevec®) --- Patient Assistance NOW Oncology (PANO) (Novartis Oncology)
• Nilotinib (Tasigna®) --- Patient Assistance NOW Oncology (PANO) (Novartis Oncology)

Thyroid Carcinoma

• Patient Access Network (PAN) Foundation (866.316.7263)

Uterine Neoplasms

• Ixabepilone (Ixempra®) --- Bristol-Myers Squibb Oncology: Reimbursement Services

ADCETRIS (brentuximab vedotin) --- Seattle Genetics - SeaGen Secure

Ado-trastuzumab emtansine (Kadcyla) --- Genentech Access Solutions

Arsenic Trioxide (Trisenox®) --- Teva Oncology: CORE (Comprehensive Oncology Reimbursement Expertise)

Avastin --- Genentech Access Solutions

Azacitidine for injection (Vidaza®) --- Celgene Patient Support®

Bendamustine (Treanda®) --- Teva Oncology: CORE (Comprehensive Oncology Reimbursement Expertise)

Bevacizumab (Avastin) --- Genentech Access Solutions

Capecitabine (Xeloda) --- Genentech Access Solutions

Carfilzomib (Kyprolis™) --- Onyx Pharmaceuticals

Cetuximab (Erbitux®) --- Bristol-Myers Squibb Oncology Reimbursement Services

Dasatinib (Sprycel®) --- Bristol-Myers Squibb Oncology Reimbursement Services

Enzalutamide capsules (XTANDI) --- XTANDI Access Services^SM

Erlotinib (Tarceva) --- Genentech Access Solutions

Everolimus (Afinitor®) --- Patient Assistance NOW Oncology (PANO) (Novartis Oncology)

Imatinib (Gleevec®) --- Patient Assistance NOW Oncology (PANO) (Novartis Oncology)

Ipilimumab (YERVOY™) --- Bristol-Myers Squibb Oncology Reimbursement Services

Ixabepilone (Ixempra®) --- Bristol-Myers Squibb OncologyReimbursement Services

Lenalidomide (Revlimid®) --- Celgene Patient Support®

Letrozole (Femara®) --- Patient Assistance NOW Oncology (PANO) (Novartis Oncology)

Nilotinib (Tasigna®) --- Patient Assistance NOW Oncology (PANO) (Novartis Oncology)

Paclitaxel, albumin-bound (Abraxane®) --- Celgene Patient Support®

Pertuzumab (Perjeta) --- Genentech Access Solutions

ponatinib (Iclusig®) --- ARIAD PASS™ (Patient Access & Support Services)

Rituximab (Rituxan) --- Genentech Access Solutions

Romidepsin for injection (Istodax®) --- Celgene Patient Support®

Ruxolitinib (tablets) (Jakafi®) --- IncyteCARES (Incyte Corporation)

Sorafenib tosylate (Nexavar®) --- REACH (Resource for Expert Assistance and Care Helpline) (Bayer HealthCare Pharmaceuticals)

Sorafenib tosylate (Nexavar®) --- REACH (Resource for Expert Assistance and Care Helpline) (Bayer HealthCare Pharmaceuticals)

Thalidomide (Thalomid®) --- Celgene Patient Support®

Trastuzumab (Herceptin) --- Genentech Access Solutions

Vemurafenib (Zelboraf) --- Genentech Access Solutions

Vismodegib (Erivedge) --- Genentech Access Solutions

Zoledronic acid (Zometa®) --- Patient Assistance NOW Oncology (PANO) (Novartis Oncology)

• ARIAD PASS™ (Patient Access & Support Services)  read more...
  
  

  Patient and Reimbursement Assistance Website
  www.ariadpass.com

  Patient Assistance
  ARIAD PASS™

  ARIAD is pleased to introduce the ARIAD Patient Access & Support Services (ARIAD PASS) program to help providers and their patients access, afford, and adhere to treatment. At ARIAD PASS, benefit coordinators are available to help providers and their patients with patient assistance (free product) and co-pay assistance programs.

  ARIAD PASS also offers dedicated oncology-certified nurses to assist patients with treatment support, disease education, and referrals to other assistance programs, upon request. The ARIAD PASS benefits coordinator provides eligible patients with an array of financial assistance options, including co-pay or coinsurance support based on their insurance coverage and financial need.

  To enroll your patient in this program, download the ARIAD PASS Enrollment Form at:
  www.ariadpass.com/ARIAD_PASS_Enrollment_Form.pdf
  Completed forms should be faxed to: 1.855.557.PASS (1.855.557.7277).
  Questions? Call 1.855.447.PASS (1.855.447.7277) Monday through Friday, 7:00 AM – 7:00 PM CST.

  Reimbursement Assistance
  ARIAD PASS

  ARIAD PASS offers coverage and reimbursement support to providers and patients.
  To ensure that patients can promptly begin therapy, a benefits coordinator can help providers determine:

  • A patient's level of insurance coverage
  • Additional requirements, such as prior authorizations
  • Any preferred specialty pharmacy
  
  

  To enroll your patient in this program, download the ARIAD PASS Enrollment Form at:
  www.ariadpass.com/ARIAD_PASS_Enrollment_Form.pdf
  Completed forms should be faxed to: 1.855.557.PASS (1.855.557.7277).
  Questions? Call 1.855.447.PASS (1.855.447.7277) Monday through Friday, 7:00 AM – 7:00 PM CST.
  www.ariadpass.com

• Astellas Pharma US, Inc.
  XTANDI Access Services℠  read more...
  
  

  - Your Patients - Your Practice - Your Choice

  XTANDI Access ServicesSM is designed as a single point of contact to help patients and their loved ones understand their coverage and reimbursement options for XTANDI (enzalutamide) capsules. Astellas is firmly committed to ensuring our patients have access to XTANDI, regardless of their financial status. We are here to answer questions about your insurance coverage and options for filling your prescription in order to get you started on therapy as quickly as possible.

  Flexible and integrated resources for patient access and support:

  • Covers the needs of patients with private insurance and Medicare, as well as uninsured patients
  • Physicians can send a prescription directly to a Specialty Pharmacy Provider in the network, HUB call center, or self-dispense out of an office based pharmacy
  • Provides patient benefit verification and support with prior authorization and appeals assistance
  
  

  XTANDI Patient Savings Program℠

  • Co-pay assistance for privately insured patients
  • One time enrollment per year or 12 monthly refills
  • Patients pay no more than $20.00/month with an annual maximum benefit of up to $12,000/year

  Quick Start+℠ for XTANDI
  To enable rapid initiation of treatment, the Quick Start+™ program for XTANDI provides a one-time, 14-day gratis fill supply of XTANDI that requires a physician prescription. Quick Start+ is intended for new patients who have not received a coverage decision from their payer (for example, a benefit verification or prior authorization is pending) in time to start therapy in 10 business days. Quick Start+™ offers several benefits:

  • Allow patients to start treatment with XTANDI while XTANDI Access ServicesSM troubleshoots issues
  • Provides quick delivery time so patients can start therapy as soon as possible
  • Offers direct-to-patient shipping

  Astellas Access Program℠
  Astellas is committed to supporting and maintaining access to medications for patients who are treated with an Astellas product.

  The Astellas Access Program℠ for XTANDI is designed for patients who have no health insurance. This program provides free XTANDI to patients who qualify for enrollment based on insurance and household income status. Eligibility is determined on a patient-specific basis. XTANDI Access Services℠ can quickly determine whether a patient is eligible for enrollment.

  If you need assistance with the Astellas eService site, XTANDI Access Services℠ or have any questions on coding, coverage, and reimbursement for Astellas products, please contact us between the hours of 9:00 AM and 8:00 PM ET Monday through Friday.

  Contact Us
  XTANDI Access Services℠
  Monday – Friday, 9:00 AM – 8:00 PM ET
  Phone: 1.855.8XTANDI (1.855.898.2634)
  Fax: 1.855.982.6341

  Mailing Address
  Astellas Access Services℠
  P.O. Box 13185
  La Jolla, CA 92039

  For Full Prescribing Information please see www.Astellas.com or contact Astellas Medical Communication at 1.800.961.0018.

  XTANDI and Astellas are trademarks of Astellas Pharma Inc.
  XTANDI Access Services℠ is a component of Astellas Access Services℠.

  www.Astellas.com

• Bristol-Myers Squibb Oncology Reimbursement Services  read more...
  
  

  Bristol-Myers Squibb Oncology is committed to helping appropriate patients get access to our medications by providing reimbursement support services for healthcare professionals.

  Bristol-Myers Squibb Oncology: Access Support is a comprehensive resource for Reimbursement Support Services and Patient Assistance that offers access services for patients including:

  • Benefit Investigation
  • Appeals Assistance
  • Alternative coverage search
  • Prior Authorization Assistance
  • Patient Assistance
  
  

  To learn more about BMS Access Support, please visit our web site or call the toll-free number to speak with a reimbursement counselor.

  Phone 1.800.861.0048
  Monday – Friday, 8:00 AM to 8:00 PM ET
  www.BMSAccessSupport.com

• BTG International Inc.  read more...
  
  

  BTG is a specialist healthcare company targeting critical care, cancer, and other disorders. Specialty pharmaceuticals approved for use in the US include CroFab^® Crotalidae Polyvalent Immune Fab (Ovine), DigiFab^® Digoxin Immune Fab (Ovine), and Voraxaze^® (glucarpidase).

  Company and product website addresses:
  www.btgplc.com
  www.crofab.com
  www.digifab.us
  www.voraxaze.com

• CancerCare^®  read more...
  
  

  Founded in 1944, CancerCare^® is dedicated to helping people affected by cancer. A national, nonprofit 501C3 organization, CancerCare provides free, professional support services to individuals, families, caregivers and the bereaved in order to help them cope with, and manage, the emotional and practical challenges of cancer.

  CancerCare services include counseling, support groups, educational publications, workshops, financial assistance and co-pay assistance. All psychosocial services are provided by professional oncology social workers. All services are offered completely free of charge.

  CancerCare serves all 50 states. To learn more, please visit www.cancercare.org. Patients and families can call 1-800-813-HOPE (4673).

• Celgene Patient Support®  read more...
  
  

  Celgene Patient Support® provides a dedicated, central point of contact for patients and healthcare professionals who use Celgene products. Celgene Patient Support® is a free service that helps patients and healthcare professionals navigate the challenges of reimbursement, providing information about co-pay assistance, and answering questions about obtaining Celgene products.

  • Facilitate prior authorization
  • Assist with appeal support after insurance denials
  • Navigate your Medicare coverage
  • Assess co-pay options
  • Follow up on your prescription status
  • Help you apply for the Celgene free medication program
  • Guide you through Celgene products and restricted distribution programs
  
  

  1.800.931.8691 or www.CelgenePatientSupport.com

• Genentech Access Solutions  read more...

  We Focus on Access So You Can Focus on Health

  If you are concerned about paying for your Genentech medicine, we are here to help. Whether you have health care coverage or not, we can help you by:

  • Finding out if your health care plan pays for your medicine
  • Guiding you through the process of getting your medicine
  • Connecting you with our patient assistance programs
  
  

  Visit Genentech-Access.com to learn more about these programs and how to get started. To speak live with one of our Specialists, call (866) 4ACCESS/(866) 422-2377.

• IncyteCARES (Incyte Corporation)  read more...
  
  

  IncyteCARES (Connecting to Access, Reimbursement, Education and Support) was established by Incyte to assist providers, patients, and caregivers through a single point of contact with reimbursement assistance, patient access, and distribution coordination for Jakafi^® (ruxolitinib).

  IncyteCARES assists healthcare professionals and eligible patients with product access through a suite of services, including:

  • Benefit verification, prior authorization and appeals assistance, and Jakafi delivery coordination
  • Co-pay assistance for privately insured patients who meet the program's eligibility requirements
  • Access to Jakafi free of charge for patients who do not have insurance and meet the program's eligibility requirements
  • Referral to independent and nonprofit organizations that may be able to provide financial assistance
  • Patient education and support
  
  

  You can contact IncyteCARES, between 8 AM – 8 PM ET, by calling 1-855-4-JAKAFI (855-452-5234) or visit www.IncyteCARES.com for more information.

• Onyx Pharmaceuticals  read more...
  
  

  Onyx 360 sets a new standard of personalized treatment support for patients, caregivers, and practices. You and your patients will have access to a dedicated Oncology Nurse Advocate and a wide range of services and support, including:
  

  • Reimbursement Assistance
  • Co-pay/Co-insurance assistance
  • Free product assistance for eligible patients
  • Clinical Support
  • Information about the disease
  • Side effect management
  • Referrals to Third-party Organizations for Day-to-Day and Emotional Support
  • Assistance with transportation to scheduled appointments
  • Patient and caregiver counseling services
  • Support group information

  Talk to Your Patients About Onyx 360 Today.
  To learn more about these services, please call 1.855.ONYX.360 (1.855.669.9360).

• Patient Access Network (PAN) Foundation (866.316.7263)  read more...
  
  

  Patient Access Network (PAN) Foundation (866.316.7263)
  PAN is an independent non-profit organization that provides assistance to underinsured patients for their out-of-pocket expenses for life-saving medications. PAN supports patients through more than 40 oncology, chronic, and rare disease funds that cover conditions such as multiple myeloma, metastatic breast cancer, and renal cell carcinoma. Since 2004, PAN has provided nearly $300 million in assistance for out-of-pocket expenses through more than 170,000 patient grants. Patients and their advocates can apply for assistance by calling 866.316.7263 or start the application process online at www.PANFoundation.org.

• Patient Assistance NOW Oncology (PANO) (Novartis Oncology)  read more...
  
  

  Helping to make access to the therapies you need easier

  Novartis Oncology is committed to helping patients living with cancer receive the medicines they need. Patient Assistance NOW Oncology offers quick and easy access to information about the broad array of support and reimbursement programs available.

  You can get information about our Patient Assistance NOW Oncology support programs in 2 ways:

  • Call 1.800.282.7630 to speak with a member of our knowledgeable staff dedicated to making access to our programs as simple and convenient as possible; or
  • Visit our website at www.OncologyAccessNow.com
  
  Support for patients includes:
  
  • Insurance verification
  • Coding/billing questions
  • Medicare education
  • Therapy-specific support programs for out-of-pocket costs
  • Alternative assistance searches and referrals to federal or state assistance programs
  • Referrals to independent charitable foundations for assistance with co-pay costs
  • Assistance with denials/appeals
  • Patient assistance for low-income and uninsured patients
  • Patients prequalifed via phone screening for the Patient Assistance Program (PAP) will be sent a 30-day supply of their needed medication while completing the application
  • Convenient provider portal to access program services or check the status of patients enrolled
  
  

  www.OncologyAccessNow.com

• REACH (Resource for Expert Assistance and Care Helpline)
  (Bayer HealthCare)  read more...
  
  

  The REACH program assists patients with their coverage options for Nexavar^® (sorafenib) tablets and Stivarga (regorafenib) tablets. Nexavar and Stivarga are distributed through designated specialty pharmacy providers (SPPs); it is not available through retail pharmacies. A REACH program counselor will work with Payers and patients to identify an SPP that will fill the Nexavar or Stivarga prescription and send it directly to the patient’s home. A REACH program counselor will also call patients to provide help in understanding insurance coverage and the Medicare Part D drug benefit and aid in finding other sources of payment for Nexavar or Stivarga. Enrollment forms are available via REACH at (866.639.2827), Monday through Friday from 9:00 AM to 8:00 PM EST, or at www.nexavar-us.com or www.stivarga-us.com. The Reimbursement Support Line team has experience with all payer types, including Medicare. Questions answered by the team typically can be classified into one of the following groups:

  • Benefit verification
  • Coding information and billing instruction
  • Claims review
  • Claims-appeal assistance
  • Prior-authorization assistance
  • Patient assistance
  
  

  The On-call Team closely monitors the reimbursement environment for latest changes in Medicare, Medicaid, and private payer reimbursement and coverage polices. In addition, Bayer HealthCare Pharmaceuticals offers a patient assistance program that provides assistance to uninsured patients who meet the program requirements.

  www.nexavar-us.com
  www.stivarga-us.com

• Seattle Genetics – SeaGen Secure  read more...
  
  

  www.seagensecure.com

  SeaGen Secure™ is a comprehensive assistance program for patients who have been prescribed ADCETRIS™ (brentuximab vedotin) and for the healthcare providers caring for them. Services offered by the program include:

  • Patient Assistance and Reimbursement Support
  • Benefits Verification
  • Prior Authorization Assistance
  • Co-insurance Assistance
  • Claims Tracking
  • Appeal Assistance and Tracking
  • Billing and Coding Support
  • General Payer and Policy Research
• Teva Oncology: CORE (Comprehensive Oncology Reimbursement Expertise)  read more...
  
  

  Teva Oncology: CORE (Comprehensive Oncology Reimbursement Expertise) offers reimbursement support for branded Teva Oncology products. Some of the options include benefit verification, prior authorization support and customer service through the claims and appeals process. CORE also provides referrals to the CephalonCARES patient assistance program.

  For more information or an introductory consult please call 1-888-587-3263 or visit www.TevaCore.com

• Telerx  read more...
  
  

  Telerx: the right partner.
  Whether you’re a bio/pharmaceutical manufacturer working to provide the latest in drug therapies or a healthcare company providing appropriate access, the complex nature of delivering quick, accurate and cost effective Access and Reimbursement services to patients and their healthcare providers can be daunting.

  It requires smart solutions focused on a deep understanding of the issues and opportunities presented by the ever changing healthcare environment. Telerx’s Access & Reimbursement services include:

  • Benefit Verifications
  • Patient Assistance Programs
  • Prior Authorizations
  • Rebates and Specialty Programs
  • Co-Pay Assistance
  • Coding and Billing Support
  • Claims Tracking
  • Adherence Programs
  • Reimbursement Hotlines
  • Patient and HCP Portal Services
  • Prescription Triage and Consulting
  • Reporting and Analytics